T. Davies

发表

Antipneumococcal Activities of Gemifloxacin Compared to Those of Nine Other Agents

P. Appelbaum, K. Credito, L. M. Kelly, 2000, Antimicrobial Agents and Chemotherapy.

Antipneumococcal Activity of Telithromycin by Agar Dilution, Microdilution, E Test, and Disk Diffusion Methodologies

P. Appelbaum, L. M. Kelly, T. Davies, 2000, Journal of Clinical Microbiology.

Antipneumococcal Activity of ABT-773 Compared to Those of 10 Other Agents

M. R. Jacobs, L. Ednie, P. Appelbaum, 2000, Antimicrobial Agents and Chemotherapy.

In Vitro Selection of Resistance to Four β-Lactams and Azithromycin in Streptococcus pneumoniae

M. R. Jacobs, P. Appelbaum, G. Pankuch, 1998, Antimicrobial Agents and Chemotherapy.

Clinical isolation and characterization of aminoglycoside-resistant small colony variants of Enterobacter aerogenes.

S. Lerner, J. Rusthoven, T. Davies, 1979, The American journal of medicine.

Antimicrobial Susceptibility and Macrolide Resistance Inducibility of Streptococcus pneumoniae Carrying erm(A), erm(B), or mef(A)

G. Syrogiannopoulos, B. Bozdoğan, I. Grivea, 2003, Antimicrobial Agents and Chemotherapy.

Identification of an erm(A) Erythromycin Resistance Methylase Gene in Streptococcus pneumoniaeIsolated in Greece

G. Syrogiannopoulos, I. Grivea, G. D. Katopodis, 2001, Antimicrobial Agents and Chemotherapy.

Two New Mechanisms of Macrolide Resistance in Clinical Strains ofStreptococcus pneumoniae from Eastern Europe and North America

P. Courvalin, F. Depardieu, M. Jacobs, 2000, Antimicrobial Agents and Chemotherapy.

Antimicrobial use and colonization with erythromycin-resistant Streptococcus pneumoniae in Greece during the first 2 years of life.

G. Syrogiannopoulos, I. Grivea, G. D. Katopodis, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevalence of Single Mutations in Topoisomerase Type II Genes among Levofloxacin-Susceptible Clinical Strains of Streptococcus pneumoniae Isolated in the United States in 1992 to 1996 and 1999 to 2000

K. Bush, A. Evangelista, D. Sahm, 2002, Antimicrobial Agents and Chemotherapy.

Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae.

M. Jacobs, P. Appelbaum, B. Dewasse, 2001, The Journal of antimicrobial chemotherapy.

Novel Ser79Leu and Ser81Ile Substitutions in the Quinolone Resistance-Determining Regions of ParC Topoisomerase IV and GyrA DNA Gyrase Subunits from Recent Fluoroquinolone-Resistant Streptococcus pneumoniae Clinical Isolates

T. Davies, R. Goldschmidt, N. Korzheva, 2005, Antimicrobial Agents and Chemotherapy.

Effect of MexXY Overexpression on Ceftobiprole Susceptibility in Pseudomonas aeruginosa

K. Bush, E. Baum, B. Foleno, 2009, Antimicrobial Agents and Chemotherapy.

Effects of Ceftobiprole and Oxacillin on mecA Expression in Methicillin-Resistant Staphylococcus aureus Clinical Isolates

K. Bush, R. Flamm, Wenchi Shang, 2009, Antimicrobial Agents and Chemotherapy.

Characterization and Dynamics of Middle Ear Fluid and Nasopharyngeal Isolates of Streptococcus pneumoniae from 12 Children Treated with Levofloxacin

K. Bush, G. Noel, R. Dagan, 2007, Antimicrobial Agents and Chemotherapy.

Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000).

K. Bush, A. Evangelista, D. Sahm, 2003, The Journal of antimicrobial chemotherapy.

Susceptibilities to Telithromycin and Six Other Agents and Prevalence of Macrolide Resistance Due to L4 Ribosomal Protein Mutation among 992 Pneumococci from 10 Central and Eastern European Countries

J. Kolman, W. Hryniewicz, M. Jacobs, 2002, Antimicrobial Agents and Chemotherapy.

Macrolide resistance phenotypes in Streptococcus pneumoniae in Santiago, Chile.

M. Joloba, M. Jacobs, S. Bajaksouzian, 2002, International journal of antimicrobial agents.

Mediterranean clone of penicillin-susceptible, multidrug-resistant serotype 6B Streptococcus pneumoniae in Greece, Italy and Israel.

R. Dagan, M. Jacobs, N. Porat, 2000, International journal of antimicrobial agents.

Molecular epidemiological survey of penicillin-resistant Streptococcus pneumoniae from Asia, Europe, and North America.

R. Goering, M. Jacobs, J. Talbot, 1999, Diagnostic microbiology and infectious disease.

Predominance of 23S rRNA Mutants among Non-Erm, Non-Mef Macrolide-Resistant Clinical Isolates of Streptococcus pneumoniae Collected in the United States in 1999-2000

K. Bush, A. Evangelista, D. Sahm, 2005, Antimicrobial Agents and Chemotherapy.

gyrA Mutations Associated with Quinolone Resistance in Bacteroides fragilis Group Strains

H. Oh, P. Appelbaum, C. Edlund, 2001, Antimicrobial Agents and Chemotherapy.

Single- and multistep selection study of the antipneumococcal activity of BMS-284756 compared to ciprofloxacin, levofloxacin, trovafloxacin and moxifloxacin.

M. Jacobs, B. Bozdoğan, P. Appelbaum, 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Antipneumococcal Activity of Ertapenem (MK-0826) Compared to Those of Other Agents

M. Jacobs, P. Appelbaum, G. Pankuch, 2002, Antimicrobial Agents and Chemotherapy.

Activity of telithromycin against 26 quinolone-resistant pneumococci with known quinolone-resistance mechanisms.

M. Jacobs, P. Appelbaum, D. Hoellman, 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Infrequent occurrence of single mutations in topoisomerase IV and DNA gyrase genes among US levofloxacin-susceptible clinical isolates of Streptococcus pneumoniae from nine institutions (1999-2003).

K. Bush, A. Evangelista, D. Sahm, 2006, The Journal of antimicrobial chemotherapy.

Evidence for efflux pumps, other than PmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae.

P. Appelbaum, T. Davies, M. Gill, 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Activities of Ceftobiprole and Other β-Lactams against Streptococcus pneumoniae Clinical Isolates from the United States with Defined Substitutions in Penicillin-Binding Proteins PBP 1a, PBP 2b, and PBP 2x

K. Bush, Wenchi Shang, T. Davies, 2006, Antimicrobial Agents and Chemotherapy.

Binding of Ceftobiprole and Comparators to the Penicillin-Binding Proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae

M. Page, K. Bush, M. Kania, 2007, Antimicrobial Agents and Chemotherapy.

In Vitro Development of Resistance to Telithromycin (HMR 3647), Four Macrolides, Clindamycin, and Pristinamycin inStreptococcus pneumoniae

P. Appelbaum, B. Dewasse, T. Davies, 2000, Antimicrobial Agents and Chemotherapy.

Activities and Postantibiotic Effects of Gemifloxacin Compared to Those of 11 Other Agents againstHaemophilus influenzae and Moraxella catarrhalis

S. Bajaksouzian, M. R. Jacobs, L. Ednie, 2000, Antimicrobial Agents and Chemotherapy.

Activities of a New Fluoroketolide, HMR 3787, and Its (Des)-Fluor Derivative RU 64399 Compared to Those of Telithromycin, Erythromycin A, Azithromycin, Clarithromycin, and Clindamycin against Macrolide-Susceptible or -Resistant Streptococcus pneumoniae and S. pyogenes

A. Bryskier, L. Ednie, P. Appelbaum, 2001, Antimicrobial Agents and Chemotherapy.

Effects of the 7-valent pneumococcal conjugate vaccine on U.S. levofloxacin-resistant Streptococcus pneumoniae.

K. Bush, A. Evangelista, D. Sahm, 2008, Microbial drug resistance.

Activities of carbapenem and comparator agents against contemporary US Pseudomonas aeruginosa isolates from the CAPITAL surveillance program.

J. Deane, D. Sahm, R. Flamm, 2013, Diagnostic microbiology and infectious disease.

Affinity of Doripenem and Comparators to Penicillin-Binding Proteins in Escherichia coli and Pseudomonas aeruginosa

K. Bush, R. Flamm, Wenchi Shang, 2008, Antimicrobial Agents and Chemotherapy.

Evaluation of PCR primers to screen for Streptococcus pneumoniae isolates and beta-lactam resistance, and to detect common macrolide resistance determinants.

M. Jacobs, K. Ubukata, P. Appelbaum, 2001, The Journal of antimicrobial chemotherapy.

Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries.

Ronald N. Jones, M. Castanheira, L. Deshpande, 2014, The Journal of antimicrobial chemotherapy.

Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.

R. Flamm, Wenchi Shang, T. Davies, 2011, The Journal of antimicrobial chemotherapy.

Effects of Amino Acid Alterations in Penicillin-Binding Proteins (PBPs) 1a, 2b, and 2x on PBP Affinities of Penicillin, Ampicillin, Amoxicillin, Cefditoren, Cefuroxime, Cefprozil, and Cefaclor in 18 Clinical Isolates of Penicillin-Susceptible, -Intermediate, and -Resistant Pneumococci

Michael R. Jacobs, M. Jacobs, P. Appelbaum, 2002, Antimicrobial Agents and Chemotherapy.

Mutations in 23S rRNA and Ribosomal Protein L4 Account for Resistance in Pneumococcal Strains Selected In Vitro by Macrolide Passage

M. Jacobs, P. Appelbaum, T. Davies, 2000, Antimicrobial Agents and Chemotherapy.

Antistaphylococcal Activities of the New Fluoroquinolone JNJ-Q2

E. Baum, S. Crespo-Carbone, Wenchi Shang, 2011, Antimicrobial Agents and Chemotherapy.

Activity of doripenem and comparator beta-lactams against US clinical isolates of Streptococcus pneumoniae with defined mutations in the penicillin-binding domains of pbp1a, pbp2b and pbp2x.

K. Bush, R. Flamm, Wenchi Shang, 2008, The Journal of antimicrobial chemotherapy.

Multidrug resistance among Acinetobacter spp. in the USA and activity profile of key agents: results from CAPITAL Surveillance 2010.

J. Deane, D. Sahm, R. Flamm, 2012, Diagnostic microbiology and infectious disease.

Assessment of the combination of doripenem plus a fluoroquinolone against non-susceptible Acinetobacter baumannii isolates from nosocomial pneumonia patients

A. Queenan, T. Davies, A. S. Lynch, 2013, Journal of chemotherapy.

In vitro Etest synergy of doripenem with amikacin, colistin, and levofloxacin against Pseudomonas aeruginosa with defined carbapenem resistance mechanisms as determined by the Etest method.

R. Flamm, T. Davies, A. S. Lynch, 2012, Diagnostic microbiology and infectious disease.

In Vitro Selection of Resistance to Clinafloxacin, Ciprofloxacin, and Trovafloxacin in Streptococcus pneumoniae

M. R. Jacobs, P. Appelbaum, B. Dewasse, 2000, Antimicrobial Agents and Chemotherapy.

Antipneumococcal Activity of BMS 284756 Compared to Those of Six Other Agents

Michael R. Jacobs, M. Jacobs, P. Appelbaum, 2002, Antimicrobial Agents and Chemotherapy.

Effect of blood dilution on recovery of organisms from clinical blood cultures in medium containing sodium polyanethol sulfonate

J. Waters, T. Davies, S. Whitaker, 1979, Journal of clinical microbiology.

In Vitro Development of Resistance to Five Quinolones and Amoxicillin-Clavulanate in Streptococcus pneumoniae

M. R. Jacobs, P. Appelbaum, B. Dewasse, 1999, Antimicrobial Agents and Chemotherapy.

Development and Qualification of an Opsonophagocytic Killing Assay To Assess Immunogenicity of a Bioconjugated Escherichia coli Vaccine

J. Poolman, T. Davies, K. Faé, 2017, Clinical and Vaccine Immunology.

Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial.

E. Bernasconi, J. Poolman, S. Harbarth, 2017, The Lancet. Infectious diseases.

Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study.

T. Tan, P. Kiratisin, S. Roberts, 2012, International journal of antimicrobial agents.

Diversity of Ribosomal Mutations Conferring Resistance to Macrolides, Clindamycin, Streptogramin, and Telithromycin in Streptococcus pneumoniae

R. Leclercq, A. Canu, Maëlle Coquemont, 2002, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of Ceftobiprole against Pathogens from Two Phase 3 Clinical Trials of Complicated Skin and Skin Structure Infections

K. Bush, M. Jacobs, Wenchi Shang, 2008, Antimicrobial Agents and Chemotherapy.

In vitro activities of ceftobiprole combined with amikacin or levofloxacin against Pseudomonas aeruginosa: evidence of a synergistic effect using time-kill methodology.

M. Kresken, B. Körber-Irrgang, T. Davies, 2011, International journal of antimicrobial agents.

O-serotype distribution of Escherichia coli bloodstream infection isolates in critically ill patients in The Netherlands.

M. Bonten, E. Dudley, J. Poolman, 2021, Vaccine.

Evaluation of Clonality and Carbapenem Resistance Mechanisms among Acinetobacter baumannii-Acinetobacter calcoaceticus Complex and Enterobacteriaceae Isolates Collected in European and Mediterranean Countries and Detection of Two Novel β-Lactamases, GES-22 and VIM-35

Ronald N. Jones, M. Castanheira, Leah N. Woosley, 2014, Antimicrobial Agents and Chemotherapy.

IMP-33, a New IMP Variant Detected in Pseudomonas aeruginosa from Sicily

Ronald N. Jones, M. Castanheira, G. Blandino, 2013, Antimicrobial Agents and Chemotherapy.

Activity of ceftobiprole against Streptococcus pneumoniae isolates exhibiting high-level resistance to ceftriaxone.

R. Flamm, T. Davies, A. S. Lynch, 2009, International journal of antimicrobial agents.

In vitro development of resistance to ceftriaxone, cefprozil and azithromycin in Streptococcus pneumoniae.

M. Jacobs, P. Appelbaum, B. Dewasse, 2000, Journal of Antimicrobial Chemotherapy.

Susceptibility to Telithromycin in 1,011 Streptococcus pyogenes Isolates from 10 Central and Eastern European Countries

J. Kolman, W. Hryniewicz, M. Jacobs, 2002, Antimicrobial Agents and Chemotherapy.

Screening of large numbers of Streptococcus pneumoniae isolates for mutations associated with fluoroquinolone resistance using an oligonucleotide probe assay.

T. Davies, R. Goldschmidt, 2002, FEMS microbiology letters.

Safety, Reactogenicity, Immunogenicity, and Dose Selection of 10-Valent Extraintestinal Pathogenic Escherichia coli Bioconjugate Vaccine (VAC52416) in Adults Aged 60–85 Years in a Randomized, Multicenter, Interventional, First-in-Human, Phase 1/2a Study

B. Spiessens, W. Haazen, T. Davies, 2023, Open forum infectious diseases.

Molecular characterisation of meticillin-resistant Staphylococcus aureus isolates from two ceftobiprole Phase 3 complicated skin and skin-structure infection clinical trials.

K. Bush, M. Jacobs, S. Bajaksouzian, 2009, International journal of antimicrobial agents.

Effects of Ceftobiprole and Oxacillin on mecA Expression in Methicillin-Resistant Staphylococcus aureus Clinical Isolates

K. Bush, R. Flamm, Wenchi Shang, 2009, Antimicrobial Agents and Chemotherapy.

Global Distribution of O Serotypes and Antibiotic Resistance in Extraintestinal Pathogenic Escherichia coli Collected From the Blood of Patients With Bacteremia Across Multiple Surveillance Studies

Aldert L. Zomer, M. Bonten, E. Dudley, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.